We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 16

A guide to anti-corruption legislation in Asia Pacific

  • Clifford Chance LLP
  • -
  • Australia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, United Kingdom, USA, Vietnam
  • -
  • June 3 2013

The purpose of this handbook is to provide an overview of the anti-corruption regimes in Asia Pacific. Each section features the key pieces of

Recent developments for the fourth quarter 2012

  • Baker & McKenzie
  • -
  • Austria, Belgium, Canada, China, Ireland, Luxembourg, Malaysia, Morocco, Philippines, Singapore, South Korea, Spain, United Kingdom, USA
  • -
  • March 18 2013

The North American Global Equity Services ("GES") practice group is pleased to provide the current edition of our Clients and Friends Newsletter

Your global workforce in Malaysia

  • Fisher & Phillips LLP
  • -
  • Malaysia, USA
  • -
  • March 8 2013

Malaysia is both exotic and magical, and we want to ensure that the management of your global workforce in Malaysia is in compliance with all

International regulatory update 21 December 2012-4 January 2013

  • Clifford Chance LLP
  • -
  • China, European Union, Germany, Hong Kong, Malaysia, Singapore, Spain, United Kingdom, USA
  • -
  • January 7 2013

Ireland commences EU Council Presidency PRIPS: ECON Committee reports on proposed Regulation on key information documents EMIR: Implementing

Employee stock plans 2012: year-end international reporting requirements

  • Jones Day
  • -
  • Australia, Canada, China, France, India, Ireland, Israel, Japan, Malaysia, Philippines, Singapore, Thailand, United Kingdom, USA, Vietnam
  • -
  • December 6 2012

This Commentary highlights some of the principal calendar and year-end reporting requirements for employee stock plans that U.S. companies most commonly encounter when offering these programs to their employees in selected jurisdictions worldwide

Preparing for year-end global stock plan reporting requirements

  • Reed Smith LLP
  • -
  • China, Malaysia, Philippines, Thailand, USA, Vietnam
  • -
  • September 21 2012

The regulatory requirements for global stock plans seem to increase every year

Recent developments for the second quarter 2012

  • Baker & McKenzie
  • -
  • Argentina, Belgium, China, European Union, France, India, Ireland, Israel, Japan, Malaysia, United Kingdom, USA
  • -
  • September 10 2012

Summer usually brings a lull in stock plan activity as companies complete the proxy season, say-on-pay votes and plan amendments

International trade compliance - August 2012

  • Baker & McKenzie
  • -
  • Argentina, Australia, Belarus, Brazil, Canada, Chile, China, European Union, Global, Hong Kong, India, Iran, Ireland, Japan, Malaysia, Mexico, Myanmar, Netherlands, New Zealand, Nicaragua, Russia, Rwanda, South Africa, Switzerland, Syria, Ukraine, United Kingdom, USA, Vanuatu , Yemen
  • -
  • August 6 2012

Covering Customs and Other Import Requirements, Export Controls and Sanctions, Trade Remedies, WTO and Anti-Corruption

Asia anti-corruption report

  • Herbert Smith Freehills LLP
  • -
  • Bangladesh, Cambodia, China, Hong Kong, India, Indonesia, Japan, Macau, Malaysia, Mongolia, Myanmar, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, United Kingdom, USA, Vietnam
  • -
  • July 19 2012

Welcome to the first edition of our Asia anti-corruption report

Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America

  • Morrison & Foerster LLP
  • -
  • Argentina, Brazil, Chile, China, Hong Kong, Japan, Malaysia, Mexico, Philippines, South Korea, Thailand, USA, Vietnam
  • -
  • June 27 2012

Patent protection for pharmaceutical products has an impact on the pharmaceutical market and innovation